ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 3159

Systemic Lupus Erythematosus Is a Risk Factor for Young Stroke: A Population-Based Cohort Study

Elizabeth V Arkema1, Elisabet Svenungsson2, Christopher Sjöwall3 and Julia F Simard4,5, 1Department of Medicine, Clinical Epidemiology Unit, Karolinska Institutet, Stockholm, Sweden, 2Department of Medicine, Karolinska Insitutet, Rheumatology Unit, Karolinska University Hospital, Stockholm, Sweden, 3Department of Clinical and Experimental Medicine, Rheumatology/AIR, Linköping, Sweden, 4Division of Epidemiology, Health Research and Policy Department, and Division of Immunology & Rheumatology, Department of Medicine, Stanford School of Medicine, Stanford, CA, 5Clinical Epidemiology Unit, Dept of Medicine, Karolinska Institutet, Stockholm, Sweden

Meeting: 2015 ACR/ARHP Annual Meeting

Date of first publication: September 29, 2015

Keywords: Cerebrovascular disease, risk and systemic lupus erythematosus (SLE)

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Tuesday, November 10, 2015

Title: Epidemiology and Public Health IV: Risk Factors and Comorbidities for SLE and Psoriatic Arthritis

Session Type: ACR Concurrent Abstract Session

Session Time: 4:30PM-6:00PM

Background/Purpose: Previous studies indicate that individuals
with SLE have a high risk of stroke but have not investigated when the highest
risk occurs. We aimed to estimate the risk of ischemic stroke (IS) and
hemorrhagic stroke (HS) in SLE compared to the general population by age, sex,
and time since diagnosis.

Methods: Adult patients (≥18y) with SLE were
identified from the National Patient Register (NPR) to create a
population-based and nationwide cohort of individuals with SLE. SLE was defined
as ≥2 SLE ICD codes in the inpatient (1969-2013) or outpatient (2001-2013)
registers with ≥1 code in a specialist clinic and ≥1 in outpatient
care. We included only those who received their first observed SLE ICD code Jan
2003 or later as a proxy for incident SLE. General population comparators were
selected from the Total Population Register alive at the SLE patient’s
estimated diagnosis date (index date) and were matched 5:1 to the SLE population
on age, sex, and county. Stroke was identified from the NPR and those with a
history of stroke at baseline were excluded. Follow-up was from index date
through first of death, stroke, emigration or end of study (Dec 2013). Age- and
sex-adjusted Cox models were used to estimate the hazard ratio (HR) for stroke comparing
SLE to non-SLE. Models were additionally stratified by sex, age at diagnosis,
attained age and time since diagnosis. Effect modification by stratification
variables was tested using the likelihood ratio test (LRT). In secondary analyses,
we estimated the HR for stroke among individuals with confirmed SLE from two
clinical cohorts.

Results: We identified 3 133 individuals with SLE and
15 504 general population comparators. The average age at SLE diagnosis was 49
and 85% were female. We observed 90 strokes in SLE (76 IS, 14 HS) and 198 in
the general population (160 IS, 38 HS). The HR for IS comparing SLE to the
general population was 2.4 (95%CI 1.9, 3.2) and the HR for HS was 1.9 (95%CI
1.0, 3.5). HRs were higher in analyses using confirmed SLE only (IS 4.2 (95%CI
2.2, 8.0), HS 4.4 (95%CI 1.2, 16.5).

The HR for IS was significantly higher in females than in males
(females HR 3.0 (95%CI 2.2, 4.1), males HR 1.5 (95%CI 0.9, 2.6); LRT p=0.01; Figure).
Younger individuals (18-49y) had the highest risk of stroke (IS HR 10.2 (95%CI
3.5, 29.7), LRT p=0.003; HS HR 7.7 (95%CI 2.2, 27.1), LRT p=0.008). The HR for
IS was similar over time since diagnosis whereas the HR for HS was higher the
further from diagnosis (LRT p=0.05), although this was based on small numbers.

Conclusion: Individuals with SLE are at high risk of both
ischemic and hemorrhagic stroke. The relative risk was especially high in
females and below the age of 50. Notably, the risk for IS was high already within
the first year of diagnosis and remained constant during the following decade.

Figure. Hazard ratios and 95% confidence intervals
for ischemic and hemorrhagic stroke stratified by sex, age and time since
diagnosis comparing individuals with SLE to the general population.

 


Disclosure: E. V. Arkema, None; E. Svenungsson, None; C. Sjöwall, None; J. F. Simard, None.

To cite this abstract in AMA style:

Arkema EV, Svenungsson E, Sjöwall C, Simard JF. Systemic Lupus Erythematosus Is a Risk Factor for Young Stroke: A Population-Based Cohort Study [abstract]. Arthritis Rheumatol. 2015; 67 (suppl 10). https://acrabstracts.org/abstract/systemic-lupus-erythematosus-is-a-risk-factor-for-young-stroke-a-population-based-cohort-study/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2015 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/systemic-lupus-erythematosus-is-a-risk-factor-for-young-stroke-a-population-based-cohort-study/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology